Generalized Anxiety Disorder (GAD)

Reviewed by our clinical advisory team Updated February 2026

A comprehensive guide to understanding persistent, excessive worry — what causes it, how it's diagnosed, and evidence-based approaches for treatment and management.

6.8M
US adults affected
2:1
Female-to-male ratio
Age 31
Average age of onset

Overview

Generalized Anxiety Disorder (GAD) is characterized by persistent, excessive worry about a variety of topics — including work, health, family, finances, and everyday matters — that is difficult to control and occurs more days than not for at least six months.[1]

Unlike the normal anxiety everyone experiences, GAD involves worry that is disproportionate to the actual likelihood or impact of anticipated events. People with GAD often recognize their anxiety is more intense than the situation warrants, yet feel unable to stop the cycle of worry.

GAD affects approximately 6.8 million adults in the United States, or about 3.1% of the population, with women twice as likely to be affected as men.[2] The average age of onset is 31 years, though symptoms can begin at any age. GAD is one of the most common anxiety disorders seen in primary care settings and frequently co-occurs with major depressive disorder.

The good news: GAD is highly treatable. Research consistently shows that cognitive behavioral therapy (CBT), medication, or a combination of both significantly reduces symptoms in the majority of patients.[3]

Symptoms

The hallmark of GAD is excessive, uncontrollable worry that persists across multiple domains of life. The DSM-5-TR requires the presence of at least three of the following six symptoms (occurring more days than not for at least six months):[1]

Physical Symptoms

GAD often manifests with prominent physical symptoms that may lead people to seek medical attention for what they believe are physical health problems:

Key distinction: While everyone worries, GAD is distinguished by the persistence (most days for 6+ months), pervasiveness (across multiple life domains), and impairment (significantly interferes with daily functioning) of the worry.

Causes & Risk Factors

GAD arises from a complex interplay of genetic, neurobiological, environmental, and psychological factors. No single cause has been identified, but research has illuminated several contributing elements.[4]

Genetic Factors

Twin studies estimate the heritability of GAD at approximately 30%, indicating a moderate genetic contribution. First-degree relatives of individuals with GAD are significantly more likely to develop the disorder. However, what may be inherited is a general vulnerability to anxiety rather than GAD specifically.[5]

Neurobiological Factors

Research has identified dysregulation in several brain systems in people with GAD, including the amygdala (threat detection), prefrontal cortex (worry regulation), and the HPA axis (stress response). Imbalances in neurotransmitters — particularly serotonin, norepinephrine, and GABA — are also implicated.

Environmental & Psychological Factors

Comorbidity

GAD rarely occurs in isolation. Studies show that approximately 90% of individuals with GAD have at least one co-occurring psychiatric condition, most commonly major depressive disorder (62%), social anxiety disorder, or another anxiety disorder.[2]

Diagnosis

GAD is diagnosed through clinical evaluation, typically by a psychiatrist, psychologist, or primary care physician. There is no laboratory test for GAD, but a thorough assessment includes:

Self-screening: Take the GAD-7 assessment — a validated 7-question tool used by clinicians worldwide. It takes about 2 minutes and can help you understand whether your symptoms may warrant professional evaluation.

Treatment Options

GAD is one of the most treatable anxiety disorders. Evidence-based treatment typically involves psychotherapy, medication, or a combination of both. The choice depends on symptom severity, patient preference, and availability of resources.[3]

Cognitive Behavioral Therapy (CBT)

CBT is considered the gold standard psychotherapy for GAD. It works by helping patients identify, challenge, and modify anxious thought patterns and avoidance behaviors. Core components include:

Meta-analyses show CBT produces large effect sizes for GAD, with response rates of 50-60% and benefits that persist after treatment ends.[7]

Medication

First-line pharmacotherapy:

Second-line options:

Important: All medication decisions should be made with a prescribing physician. Never start, stop, or adjust psychiatric medication without medical supervision.

Combination Therapy

For moderate-to-severe GAD, combining CBT with medication often produces the best outcomes. Research suggests combination therapy may be particularly beneficial for patients who do not respond adequately to either approach alone.[3]

Self-Help Strategies

While professional treatment is recommended for GAD, several evidence-based self-help strategies can complement therapy and medication:

Lifestyle Modifications

Mindfulness and Relaxation

Cognitive Techniques

When to Seek Help

Consider seeking professional help if:

Crisis support: If you are in crisis or experiencing suicidal thoughts, contact the 988 Suicide & Crisis Lifeline by calling or texting 988. Available 24/7.

Early intervention leads to better outcomes. GAD is a chronic condition, but with appropriate treatment, most people experience significant improvement in symptoms and quality of life. Your primary care physician is a good starting point, as they can provide initial assessment and referrals to mental health specialists.

References

  1. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). DSM-5-TR.
  2. National Institute of Mental Health. (2024). Generalized Anxiety Disorder. nimh.nih.gov.
  3. Cuijpers, P., et al. (2014). Cognitive behavior therapy vs. control conditions for anxiety disorders. World Psychiatry, 13(3), 316-327. PubMed.
  4. Hettema, J. M., Neale, M. C., & Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry, 158(10), 1568-1578. PubMed.
  5. Shimada-Sugimoto, M., et al. (2015). Genetics of anxiety disorders. Psychiatry and Clinical Neurosciences, 69(7), 388-401. PubMed.
  6. Spitzer, R. L., et al. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092-1097. PubMed.
  7. Hofmann, S. G., et al. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427-440. PubMed.
  8. Stonerock, G. L., et al. (2015). Exercise as treatment for anxiety. Annals of Behavioral Medicine, 49(4), 542-556. PubMed.

Take the Next Step

Whether you're assessing your symptoms or ready to find professional support, we can help.